Management of herpesvirus infections in the healthy host.

Pharmacotherapy

Antiinfective Pharmacology Research Unit, University of Rhode Island College of Pharmacy, Roger Williams Medical Center, Providence 02908-4734, USA.

Published: March 1996

AI Article Synopsis

  • Human herpesvirus infections can pose serious risks to both healthy individuals and those with weakened immune systems, often leading to life-threatening conditions in immunocompromised patients.
  • In healthy people, these infections are usually self-limiting but can still cause significant discomfort and reduce productivity, which has been highlighted by financial analysis models.
  • Treatment for these infections in immunocompetent individuals focuses on quickly resolving symptoms and episodes to minimize their overall impact.

Article Abstract

Human herpesvirus infections continue to be a concern in immunocompetent as well as immunocompromised hosts. They are often life threatening in the immunocompromised patient. In the healthy immunocompetent person the infections tend to be self-limited, although they can directly or indirectly cause periods of severe discomfort and disability, and their treatment can affect productivity, as shown by cost-outcome models. Treatment of primary or secondary episodes in the immunocompetent host is therefore directed toward more rapid resolution of initial and recurrent episodes, thereby limiting the impact of the infections.

Download full-text PDF

Source

Publication Analysis

Top Keywords

herpesvirus infections
8
management herpesvirus
4
infections
4
infections healthy
4
healthy host
4
host human
4
human herpesvirus
4
infections continue
4
continue concern
4
concern immunocompetent
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!